Publication: Liver cirrhosis and sarcopenia: a dreadful combination.
Loading...
Identifiers
Date
2022-09-05
Authors
Kuchay, Mohammad Shafi
Martinez-Montoro, Jose Ignacio
Llamoza-Torres, Camilo Julio
Fernandez-Garcia, Jose Carlos
Ramos-Molina, Bruno
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
AME Publishing Company
Abstract
Patients with liver cirrhosis, irrespective of etiology, have increased risk of liver-related and all-cause mortality (1). Also, the severity of cirrhosis determines health outcomes. For instance, patients with compensated cirrhosis have a nearly five-fold increased risk of death, while those with decompensated cirrhosis have approximately a 10-fold increased risk compared with the general population (1). Furthermore, the median survival time of patients with compensated cirrhosis is 12 years, while it is only 1.8 years in those with decompensated cirrhosis (2). Moreover, the presence of intercurrent conditions, such as sarcopenia (loss of skeletal muscle mass and function) may also compromise the prognosis of patients with cirrhosis (3).
Description
MeSH Terms
Humans
Prognosis
Muscle, Skeletal
Outcome Assessment, Health Care
Prognosis
Muscle, Skeletal
Outcome Assessment, Health Care
DeCS Terms
Fibrosis
Músculo esquelético
Hígado
Pronóstico
Cirrosis hepática
Músculo esquelético
Hígado
Pronóstico
Cirrosis hepática
CIE Terms
Keywords
Fibrosis, Sarcopenia, Death, Liver Cirrhosis, Mortality
Citation
Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-731